Globus Medical ROA 2010-2018 | GMED

Current and historical return on assets (ROA) values for Globus Medical (GMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Globus Medical ROA for the three months ending September 30, 2018 was 14.02%.
Globus Medical ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.14B $1.24B 12.41%
2018-06-30 $0.14B $1.19B 12.17%
2018-03-31 $0.12B $1.13B 11.23%
2017-12-31 $0.11B $1.08B 10.61%
2017-09-30 $0.11B $1.04B 11.02%
2017-06-30 $0.11B $1.00B 11.41%
2017-03-31 $0.11B $0.96B 11.48%
2016-12-31 $0.10B $0.93B 11.75%
2016-09-30 $0.12B $0.90B 13.70%
2016-06-30 $0.12B $0.87B 14.11%
2016-03-31 $0.12B $0.84B 14.32%
2015-12-31 $0.11B $0.83B 14.38%
2015-09-30 $0.10B $0.80B 13.67%
2015-06-30 $0.10B $0.77B 13.99%
2015-03-31 $0.10B $0.74B 14.31%
2014-12-31 $0.09B $0.70B 14.49%
2014-09-30 $0.09B $0.65B 14.16%
2014-06-30 $0.08B $0.62B 14.38%
2014-03-31 $0.07B $0.60B 12.61%
2013-12-31 $0.07B $0.57B 13.18%
2013-09-30 $0.07B $0.53B 13.99%
2013-06-30 $0.06B $0.50B 13.95%
2013-03-31 $0.08B $0.47B 17.84%
2012-12-31 $0.07B $0.45B 18.68%
2012-09-30 $0.07B $0.42B 18.27%
2012-06-30 $0.07B $0.37B 25.88%
2012-03-31 $0.06B $0.36B 36.26%
2011-12-31 $0.06B $0.33B 68.09%
2011-09-30 $0.04B $0.00B 62.92%
2011-06-30 $0.03B $0.00B 37.45%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.097B $0.636B
Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $97.045B 22.61
Intuitive Surgical (ISRG) United States $59.217B 58.26
Edwards Lifesciences (EW) United States $32.551B 34.83
Fresenius Medical Care AG KGaA (FMS) Germany $24.608B 16.66
IDEXX Laboratories (IDXX) United States $17.365B 49.60
ABIOMED (ABMD) United States $14.403B 103.49
DexCom (DXCM) United States $12.274B 0.00
Teleflex (TFX) United States $12.055B 27.37
Hologic (HOLX) United States $11.459B 18.80
Varian Medical Systems (VAR) United States $10.872B 26.93
STERIS (STE) United Kingdom $10.002B 26.54
LivaNova (LIVN) United Kingdom $6.106B 39.19
Masimo (MASI) United States $5.811B 37.68
Penumbra (PEN) United States $4.712B 284.52
Integra LifeSciences Holdings (IART) United States $4.624B 22.52
Wright Medical Group (WMGI) Netherlands $3.695B 0.00
Cantel Medical (CMD) United States $3.586B 36.13
Inogen (INGN) United States $3.026B 65.32
Integer Holdings (ITGR) United States $2.776B 23.23
Halyard Health (AVNS) United States $2.304B 20.76
Glaukos (GKOS) United States $2.142B 0.00
OPKO Health (OPK) United States $1.993B 0.00
Tandem Diabetes Care (TNDM) United States $1.921B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
AxoGen (AXGN) United States $1.225B 0.00
Nevro (NVRO) United States $1.217B 0.00
Luminex (LMNX) United States $1.204B 43.56
Natus Medical (BABY) United States $1.146B 24.06
Pacific Biosciences Of California (PACB) United States $1.123B 0.00
Orthofix (OFIX) United States $1.108B 32.01
CryoLife (CRY) United States $1.094B 95.93
Tactile Systems Technology (TCMD) United States $1.081B 172.12
Intersect ENT (XENT) United States $0.952B 0.00
AngioDynamics (ANGO) United States $0.806B 28.19
Accelerate Diagnostics (AXDX) United States $0.782B 0.00
Mesa Laboratories (MLAB) United States $0.768B 45.43
ViewRay (VRAY) United States $0.663B 0.00
Veracyte (VCYT) United States $0.562B 0.00
Sientra (SIEN) United States $0.522B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.419B 0.00
Accuray (ARAY) United States $0.408B 0.00
SI-BONE INC (SIBN) United States $0.407B 0.00
Quotient (QTNT) Switzerland $0.374B 0.00
OrthoPediatrics (KIDS) United States $0.365B 0.00
Nuvectra (NVTR) United States $0.325B 0.00
Fluidigm (FLDM) United States $0.322B 0.00
Neuronetics (STIM) United States $0.318B 0.00
IRadimed (IRMD) United States $0.299B 78.06
SeaSpine Holdings (SPNE) United States $0.285B 0.00
GenMark Diagnostics (GNMK) United States $0.280B 0.00
RTI Surgical (RTIX) United States $0.278B 43.80
Pulse Biosciences (PLSE) United States $0.215B 0.00
T2 Biosystems (TTOO) United States $0.204B 0.00
Helius Medical Technologies (HSDT) United States $0.189B 0.00
Ekso Bionics Holdings (EKSO) United States $0.127B 0.00
Alphatec Holdings (ATEC) United States $0.123B 0.00
Ra Medical Systems (RMED) United States $0.103B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Second Sight Medical Products (EYES) United States $0.090B 0.00
Apollo Endosurgery (APEN) United States $0.077B 0.00
EDAP TMS (EDAP) France $0.076B 0.00
Restoration Robotics (HAIR) United States $0.072B 0.00
Viveve Medical (VIVE) United States $0.068B 0.00
Biosig Technologies (BSGM) United States $0.066B 0.00
OBALON THERPTCS (OBLN) United States $0.046B 0.00
Vermillion (VRML) United States $0.038B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
PAVmed (PAVM) United States $0.027B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
ENDRA Life Sciences (NDRA) United States $0.022B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Bioanalytical Systems (BASI) United States $0.015B 0.00
Presbia (LENS) Ireland $0.012B 0.00
Microbot Medical (MBOT) United States $0.010B 0.00
ReWalk Robotics (RWLK) Israel $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.003B 0.00
Amedica (SINT) United States $0.003B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00